Effect of Sasa quelpaertensis Nakai extract consumption on body fat reduction in obesity adults
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0000654
- Lead Sponsor
- Jeju National University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 90
1) Voluntarily agree to participate and sign in informed consent form
2) Men or women aged 20-65 years
3) BMI: 25kg/m2 = ~ = 35kg/m2
1) Continuous consumption of antiobesity drugs(absorption inhibitors, antidepressants, anorexing agents), diuretic, contraceptive, steroids, female hormone that affect body weight
2) Continuous consumption of dietary supplement or oriental medicine within 4 weeks before the first visit
3) Consumption of dietary supplement for body weight control or participation in commercial obesity program within 8 weeks before first visit
4) Expereienced with surgery like bowel resection for weight loss
5) Following diseases:
? Uncontrolled hypertension (=140/90mmHg)
? Diabetes (fasting blood glucose =126 mg/dL)
? Liver dysfunction (AST, ALT = 2.5 times of the upper limit of normal level)
? Renal dysfunction(Creatinine=1.2mg/dL)
? Hyperthiroidism and hypothyroidism
? Malignant tumors
6) Hypersensitivity to Sasa quelpaertensis Nakai
7) Participation of another clinical trials within 4 weeks before the first visit
8) Pregnant or lactating women
9) Any condition that the principal investigator belives may put the subjects at undue risk
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method body fat-related biomarkers
- Secondary Outcome Measures
Name Time Method lipid profile